You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
九洲藥業(603456.SH):蘇州諾華正在進行資產剝離工作 目前審計工作已完成
格隆匯 11-29 22:25

格隆匯11月29日丨九洲藥業(603456.SH)公佈,為進一步提升公司作為諾華集團全球供應鏈中戰略供應商的地位,優化公司創新藥CDMO一站式服務能力,加快擴充公司CDMO項目儲備,促進業務增長,公司於2019年9月4日召開第六屆董事會第十七次會議,會議審議通過了《關於擬收購蘇州諾華製藥科技有限公司100%股權的議案》,同意公司與Novartis International Pharmaceutical Investment Ltd.(諾華國際製藥投資有限公司,“諾華投資”)簽署《股權收購協議》,擬預估以約7.9億元人民幣的自籌資金收購諾華投資所持有的剝離技術與藥品開發資產後的蘇州諾華製藥科技有限公司(“蘇州諾華”)100%股權,收購完成後蘇州諾華將成為九洲藥業全資子公司。此次交易正式交割之前,標的公司需要進行技術與藥品開發資產的剝離,最終交易價格將根據標的公司在交割日的現金、負債及營運資金等相關情況作相應調整。

截止公告日,蘇州諾華正在進行資產剝離工作。目前此次交易標的的審計工作已完成,具有證券、期貨業務資格的天健會計師事務所(特殊普通合夥)就蘇州諾華剝離技術與藥品開發資產後的原料藥生產和銷售業務的2018年度、2019年1-7月份模擬財務報表出具了天健審【2019】9399號《審計報告》。按照《上海證券交易所股票上市規則》和《公司章程》的相關要求,公司於2019年11月29日召開第六屆董事會第二十次會議,會議審議通過了《關於對外投資收購蘇州諾華製藥科技有限公司100%股權的議案》,該議案尚需提交股東大會審議通過。獨立董事發表了同意的獨立意見。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account